Purchase Order 75F40125P00271
- Not listed
- This is a fixed-price purchase order contract awarded by the Food and Drug Administration (FDA) to Life Technologies Corporation, a manufacturer of scientific instruments, reagents, and consumables. The contract is for the delivery of cryopreserved human hepatocytes, which are used to support biomedical research, medical readiness, and other federal initiatives. The contract has a ceiling value of $127,649.76 and a completion date of August 7, 2020. Life Technologies serves as a prime contractor...
- This is a firm fixed-price purchase order awarded by the National Center for Advancing Translational Sciences (NCATS), a civilian agency within the U.S. Department of Health and Human Services, to Life Technologies Corporation, a manufacturer of scientific instruments, reagents, and consumables. The $24,262.29 contract is for the delivery of primary human hepatocytes, which are a critical reagent used in biomedical research supported by NCATS. This contract is not associated with any set-aside...
- Life Technologies Corporation, a subsidiary of Thermo Fisher Scientific Inc. and headquartered in Grand Island, New York, has been awarded a $19,550.44 firm fixed-price purchase order for TaqMan lab supplies by the Office of Research and Development. The award was made on December 8, 2025, with an ultimate completion date of January 30, 2026. This non-set-aside contract represents a child award, likely issued under one of Life Technologies' existing indefinite delivery vehicles with federal...
- Life Technologies Corporation (doing business as Thermo Fisher Scientific) was awarded a Blanket Purchase Agreement (BPA) call contract valued at $12,460 by the Office of Logistics and Acquisition Operations, a civilian federal agency, on January 6, 2017, with an ultimate completion date of April 30, 2017. The contract is for drugs and biologicals under a firm fixed-price arrangement with no set-aside designation. Performance will take place in Grand Island, New York. This award represents a...
- Life Technologies Corporation, doing business as Thermo Fisher Scientific, was awarded a $3,919.80 firm fixed-price Blanket Purchase Agreement (BPA) call by the National Institute of Environmental Health Sciences (NIEHS) on September 6, 2016, with an ultimate completion date of April 30, 2017. The contract was performed in Grand Island, New York, and no set-aside designation was utilized in this procurement. This award represents a task order under an existing BPA vehicle, through which Life...
- The Food and Drug Administration (FDA) awarded a $91,630 firm-fixed-price purchase order contract to Discovery Life Sciences, LLC, a small disadvantaged business, for the delivery of 110 vials of primary cryopreserved human hepatocytes. This requirement supports the FDA's National Center of Toxicological Research (NCTR) Division of Biochemical Toxicology's research into drug toxicity and metabolic enzymes. The contract has a period of performance through August 19, 2024 and was awarded under a...
- This federal contract award, valued at $80,606.37, was issued by the Food and Drug Administration (FDA) to Life Technologies Corporation, a subsidiary of Thermo Fisher Scientific, to procure a live cell imaging system. The contract is a firm fixed-price purchase order with a completion date of September 29, 2023. The contract does not involve any set-aside designation. Life Technologies Corporation is a leading provider of biomedical research and genetic analysis tools and technologies, and...
- Life Technologies Corporation, doing business as Thermo Fisher Scientific, received a $4,795 firm fixed price contract award from the National Center for Advancing Translational Sciences on December 8, 2014, with an ultimate completion date of April 30, 2015. This award was issued as a Blanket Purchase Agreement (BPA) call with no set-aside designation, reflecting the contractor's competitive positioning in federal scientific procurement. The contract concerns LanthaScreen assays for Menghang...
- Life Technologies Corporation, doing business as Thermo Fisher Scientific, received a contract award from the Office of Logistics and Acquisition Operations on August 18, 2016, for the supply of drugs and biologicals. This $11,055 firm fixed-price BPA call award was completed by April 30, 2017, and performed in Carlsbad, California. The contract utilized no set-aside designation, reflecting the contractor's competitive standing in federal procurement. As a leading manufacturer of scientific...
- Life Technologies Corporation, doing business as Thermo Fisher Scientific, received a federal contract award on April 21, 2015, valued at $5,040.00 for the procurement of drugs and biologicals. This Blanket Purchase Agreement (BPA) call was awarded on a firm fixed-price basis without a set-aside designation by a civilian federal agency under the Office of the Director. The work is scheduled for completion by April 30, 2015, with performance taking place in Carlsbad, California. Life Technologies...
Life Technologies Corporation, a subsidiary of Thermo Fisher Scientific Inc. and headquartered in Grand Island, New York, has been awarded a $48.9K firm fixed-price purchase order by the Food and Drug Administration (FDA) for cryopreserved human hepatocytes, with a completion date of September 24, 2026. The contract, awarded on September 19, 2025, with no set-aside designation, will be performed at the vendor's location in Grand Island, NY. Life Technologies Corporation is a leading supplier of biomedical research tools and life sciences products to federal agencies, specializing in laboratory equipment, reagents, genetic analysis systems, and related services. Cryopreserved hepatocytes are critical biological materials used in pharmaceutical testing, drug metabolism studies, and toxicology research—applications directly aligned with the FDA's mission to ensure drug safety and efficacy. The FDA's procurement of these specialized cellular products supports the agency's regulatory science initiatives and testing capabilities for evaluating therapeutic compounds. This purchase order represents a continuation of Life Technologies' extensive federal contracting history with the FDA and other health-related agencies, including the National Institutes of Health and Centers for Disease Control and Prevention, where the company has consistently provided specialized scientific products and services essential to federal research and regulatory functions.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $48.9k | 9/19/25 |